Thursday, November 8, 2012

• Why Seattle Genetics Shares Plungedat Motley Fool (Thu, Nov 8)
• Perrigo Downgraded to Above Average and 2 Analyst-Downgraded Shares to Watchat Wall St. Cheat Sheet (Thu, Nov 8)
• HCA and Other Healthcare Stocks Making Big Moves on November 8, 2012at Investopedia (Thu, Nov 8)
• Thursday's Top Upgrades (and Downgrades)Motley Fool (Thu, Nov 8)
• ImmunoGen Is Living Life in the Fast Laneat Motley Fool (Thu, Nov 8)
• Ahead of the Bell: Analyst lowers Seattle GeneticsAP (Thu, Nov 8)

Wednesday, November 7, 2012

• Seattle Genetics Management Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Nov 7)
• Seattle Genetics Earnings: Loss Narrowsat Wall St. Cheat Sheet (Wed, Nov 7)
• SEATTLE GENETICS INC /WA Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online (Wed, Nov 7)
• Seattle Genetics sees 2012 revenues from Adcetris $132M-$137Mtheflyonthewall.com (Wed, Nov 7)
• Seattle Genetics Reports Third Quarter 2012 Financial ResultsBusiness Wire (Wed, Nov 7)
• Seattle Genetics Third Quarter Earnings Sneak Peekat Wall St. Cheat Sheet (Wed, Nov 7)

Tuesday, November 6, 2012

• 5 Earnings Short-Squeeze Plays to Tradeat TheStreet (Tue, Nov 6)

Monday, November 5, 2012

• Seattle Genetics’ ASH 2012 Presentations Highlight ADCETRIS® and Demonstrate Leadership in the Development of Antibody-Drug Conjugates (ADCs)Business Wire (Mon, Nov 5)

Friday, November 2, 2012

• 3 Things to Watch With Seattle Geneticsat Motley Fool (Fri, Nov 2)
• SEATTLE GENETICS INC /WA Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Nov 2)

Thursday, November 1, 2012

• A Simple Path to Biotechnology Winnersat Motley Fool (Thu, Nov 1)

Wednesday, October 31, 2012

• BioCryst Withdraws Application, Glaxo’s Q3 Miss: Healthcare Business Recapat Wall St. Cheat Sheet (Wed, Oct 31)
• Seattle Genetics’ Adcetris approved for sale in Europeat bizjournals.com (Wed, Oct 31)

Wednesday, October 24, 2012

• Going Back for Drug Tech Secondsat Motley Fool (Wed, Oct 24)

Tuesday, October 23, 2012

• Eisai Wins FDA Approval, Glaxo Seeking Alzheimer’s Investment: Healthcare Business Recapat Wall St. Cheat Sheet (Tue, Oct 23)
• Seattle Genetics expands collaboration with AbbottAP (Tue, Oct 23)
• Are Short Sellers On to Something at Questcor Pharmaceuticals?at Motley Fool (Tue, Oct 23)

Thursday, October 18, 2012

• Healthcare Business Wrap: Seattle Genetics Begins Trial, Abbott Lays Off Hundredsat Wall St. Cheat Sheet (Thu, Oct 18)

Wednesday, October 17, 2012

• 3 Stocks to Get on Your Watchlistat Motley Fool (Wed, Oct 17)

Add SGEN News to My Yahoo!